An Evaluation of the Antioxidant and Anticancer Properties of Complex Compounds of Copper (II), Platinum (II), Palladium (II) and Ruthenium (III) for Use in Cancer Therapy
- PMID: 29692246
- DOI: 10.2174/1389557518666180423145825
An Evaluation of the Antioxidant and Anticancer Properties of Complex Compounds of Copper (II), Platinum (II), Palladium (II) and Ruthenium (III) for Use in Cancer Therapy
Abstract
The incidence of head and neck cancer increases every year, and represents a significant problem for Molecular Biology at the beginning of the Twenty-first Century. Despite advances in treatment, most studies still strive to deepen the understanding of the mechanisms of cancerogenesis. In order to develop more effective methods of diagnosis and therapy, it is necessary to understand the molecular basis of the neoplastic transformation process. Such findings obtained by research into Molecular Biology, Molecular Epidemiology and Genetics have brought significant progress in understanding the complex, multi- step process which takes place during tumor formation. For many years, there has been great interest in the use of complex compounds, particular complexes between heterocyclic compounds and the metals Pt (II), Pd (II), Cu (II) and Ru (III). One such compound is an azole called pyrazole; the azoles are known to have analgesic, antipyretic, anti-tumor, anti-inflammatory and anti-fungal effects. Improved synthetic and separation methods and biochemical techniques have improved the identification of compounds with biological activity. The main aim of this review is to present complexes with Pt (II), Pd (II), Cu (II) and Ru (III) ions which demonstrate antioxidant and anti-cancer properties.
Keywords: Cu(II); Pyrazoles; Ru(III) and Pd(II); anticancer properties; antioxidant; antioxidative barrier; chemiotherapeutics; complexes of Pt(II)..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.Inorg Chem. 2018 Mar 5;57(5):2917-2924. doi: 10.1021/acs.inorgchem.8b00053. Epub 2018 Feb 13. Inorg Chem. 2018. PMID: 29436828
-
Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.Colloids Surf B Biointerfaces. 2019 Oct 1;182:110373. doi: 10.1016/j.colsurfb.2019.110373. Epub 2019 Jul 26. Colloids Surf B Biointerfaces. 2019. PMID: 31376689 Review.
-
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes.Dalton Trans. 2018 Nov 21;47(43):15477-15486. doi: 10.1039/c8dt02965b. Epub 2018 Oct 18. Dalton Trans. 2018. PMID: 30334060
-
Ruthenium(ii) and palladium(ii) homo- and heterobimetallic complexes: synthesis, crystal structures, theoretical calculations and biological studies.Dalton Trans. 2019 Nov 14;48(42):15869-15887. doi: 10.1039/c9dt02353d. Epub 2019 Oct 16. Dalton Trans. 2019. PMID: 31620752
-
Noble metal-dithiocarbamates precious allies in the fight against cancer.Mini Rev Med Chem. 2012 Oct;12(12):1216-29. doi: 10.2174/138955712802762004. Mini Rev Med Chem. 2012. PMID: 22931593 Review.
Cited by
-
Evaluation of Antiproliferative Palladium(II) Complexes of Synthetic Bisdemethoxycurcumin towards In Vitro Cytotoxicity and Molecular Docking on DNA Sequence.Molecules. 2021 Jul 20;26(14):4369. doi: 10.3390/molecules26144369. Molecules. 2021. PMID: 34299644 Free PMC article.
-
Self-assembled ruthenium (II) metallacycles and metallacages with imidazole-based ligands and their in vitro anticancer activity.Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4090-4098. doi: 10.1073/pnas.1818677116. Epub 2019 Feb 14. Proc Natl Acad Sci U S A. 2019. PMID: 30765514 Free PMC article.
-
Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.Biomolecules. 2020 Apr 30;10(5):697. doi: 10.3390/biom10050697. Biomolecules. 2020. PMID: 32365821 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical